TickerFacts.

Castle Biosciences Inc (CSTL): Operating Income

Annual figures by period end, from SEC filings.

-$42.81M
Year ended 2025-12-31
-$32.11M
Trailing 12 months to 2026-06-30
$8.67M2018-12-31: -$3.84M2019-12-31: $7.33M2020-12-31: -$6.54M2021-12-31: -$40.08M2022-12-31: -$72.86M2023-12-31: -$67.98M2024-12-31: $8.67M2025-12-31: -$42.81M-$42.81M
2018-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$42.81Mn/m2026-02-26, From 2025-01-01
2024-12-31$8.67Mn/m2026-02-26, From 2024-01-01
2023-12-31-$67.98Mn/m2026-02-26, From 2023-01-01
2022-12-31-$72.86Mn/m2025-02-27, From 2022-01-01
2021-12-31-$40.08Mn/m2023-02-28, From 2021-01-01
2020-12-31-$6.54Mn/m2022-02-28, From 2020-01-01
2019-12-31$7.33Mn/m2021-03-11, From 2019-01-01
2018-12-31-$3.84Mn/a2020-03-10, From 2018-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Castle Biosciences Inc (CSTL)2025-12-31-$42.81Mn/m
Fulgent Genetics, Inc. (FLGT)2025-12-31-$91.10Mn/m
CareDx, Inc. (CDNA)2025-12-31-$30.78Mn/m
BillionToOne, Inc. (BLLN)2025-12-31$16.02Mn/m
Veracyte, Inc. (VCYT)2025-12-31$57.78M+257.9%
GRAIL, Inc. (GRAL)2025-12-31-$562.16Mn/m
Caris Life Sciences, Inc. (CAI)2025-12-31$45.11Mn/m
Guardant Health, Inc. (GH)2025-12-31-$437.25Mn/m
Biodesix Inc (BDSX)2025-12-31-$27.87Mn/m

Compare CSTL, FLGT, CDNA, BLLN side by side · Screen every company in Services-Medical Laboratories ↗